Hindustan TimesBusiness
Why global pharma is betting on India’s next-generation CDMOs
India’s pharmaceutical outsourcing pitch is evolving beyond low costs. Global drugmakers are increasingly looking to next-generation contract development and manufacturing partners for stronger capabilities, helping the country compete for more complex work across the medicines supply chain.
This card is an AI-assisted summary of reporting published by Hindustan Times. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.